| Jun'18 | Jun'17 | Jun'16 | Jun'15 | ||
|---|---|---|---|---|---|
Research and development expenses, net | |||||
1,737 | 1,997 | 1,081 | 1,375 | ||
General and administrative expenses | |||||
950 | 810 | 894 | 1,193 | ||
Operating loss | |||||
-2,687 | -2,807 | -1,975 | -2,568 | ||
Finance income (expenses), net | |||||
30 | -20 | -15 | 132 | ||
Loss before tax | |||||
-2,657 | -2,827 | -1,990 | - | ||
Taxes on income | |||||
-2 | 3 | 0 | - | ||
Net loss for the period | |||||
-2,655 | -2,830 | -1,990 | -2,436 | ||
Net loss per ordinary share basic and diluted | |||||
0.70 | 2.02 | 0.15 | 0.18 | ||
Weighted average number of ordinary shares outstanding - basic and diluted (in thousands) | |||||
3,796 | 1,403 | 13,274 | 13 | ||